Mr Kutay is chief executive officer of Novo Holdings A/S, Denmark.
Mr Kutay is member of the board of Novozymes A/S, Denmark, of Evotec
SE, Germany and of the Life Sciences Advisory Board of Gimv NV, Belgium.
From 2009 to 2016 Kasim Kutay was managing director, co-head of
Europe and member of the Global Management Committee of Moelis &
Co., UK. From 2007 to 2009 Mr Kutay was managing director and head of
Financial Solutions Group of SUN Group, UK. From 1989 to 2007 Mr Kutay
held a number of positions at Morgan Stanley, UK, including chair of
the European Healthcare Group. Mr Kutay was member of the Board of
Trustees of Northwick Park Institute for Medical Research, UK, from
2005 to 2016. Mr Kutay was member of the Board of Governors from 2006
to 2011 and the Investment Committee from 2011 to 2016 of the School
of Oriental and African Studies (SOAS), UK.
Mr Kutay was first elected to the Board of Novo Nordisk A/S in March
2017 and has most recently been re-elected in March 2020. His term as
a board member expires in March 2021.
In March 2020, the Board of Directors of Novo Nordisk A/S
assessed that Mr Kutay is not regarded as an independent board
member as defined in Section 3.2.1 of the Danish Recommendations on
Corporate Governance designated by Nasdaq Copenhagen due to Mr Kutay
being the chief executive officer of Novo Holdings A/S.
Mr Kutay became a member of the Nomination Committee at Novo
Nordisk A/S in March 2017 and Mr Kutay became member of the Research
& Development Committee at Novo Nordisk A/S in March 2020.
The Board of Directors has assessed that the special competences
possessed by Mr Kutay that are important for the performance of his
duties are his extensive experience as an investor in the life science
sector. Further, Mr Kutay manages an investment fund that invests in
life science companies at all stages of development including the
venture, growth and developed stages and has extensive experience as
financial advisor to the pharmaceutical, biotechnology and medical
device industries. Mr Kutay has also advised healthcare companies on
an international basis including companies based in Europe, the US,
Japan and India.
Mr Kutay is a UK national, born May 1965.